Andrew Cunningham, Ph.D., has been named vice president of central laboratory services at PPD. Dr. Cunningham brings extensive biopharmaceutical industry experience having held multiple leadership positions, including most recently at Advanced Diagnostic Laboratories for National Jewish Health. Previously, he was with Celerion, where he provided leadership for first-in-human bioanalytical, bioequivalence and pharmacokinetics studies in a GLP environment.
 
“Andrew’s vision and expertise strengthen PPD’s world-class laboratory services team,” said David Johnston, Ph.D., executive vice president of global laboratory services. “Central labs play a critical role in the drug development process and can drive operational efficiencies as clinical research becomes increasingly complex and geographically distributed. Andrew’s leadership will help ensure we deliver quality data, speed, flexibility and efficiencies to complete projects on time and on budget for our clients.”